Mesa Laboratories (MLAB) Convertible Debt (2019 - 2024)

Mesa Laboratories has disclosed Convertible Debt across 6 years of filings, most recently posting $96.9 million for Q2 2024.

• Convertible Debt for Q2 2024 came in at $96.9 million, down 43.17% year-over-year; the trailing twelve-month figure through Jun 2024 was $96.9 million (down 43.17% YoY), and the FY2024 annual result was $171.2 million, up 0.54% from the prior year.
• Convertible Debt came in at $96.9 million for Q2 2024 at Mesa Laboratories, down from $171.2 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $171.2 million in Q1 2024 to a low of $96.9 million in Q2 2024.
• The 5-year median for Convertible Debt is $169.3 million (2021), against an average of $158.4 million.
• Across the five-year window, Convertible Debt gained 19.13% in 2021 and sank 43.17% in 2024, its largest moves.
• Mesa Laboratories' Convertible Debt stood at $144.3 million in 2020, then advanced by 17.21% to $169.1 million in 2021, then increased by 0.53% to $170.0 million in 2022, then climbed by 0.54% to $171.0 million in 2023, then slumped by 43.32% to $96.9 million in 2024.
• The last three Convertible Debt figures came in at $96.9 million (Q2 2024), $171.2 million (Q1 2024), and $171.0 million (Q4 2023), per Business Quant data.